The Locks Law Firm is now investigating claims against e-cigarette "juice" manufacturers. A recent Harvard study revealed that a number of manufacturers were selling juices which contained diacetyl and other chemicals without indicating the presence of those chemicals or including warnings related to those chemicals on their labels. Two of the manufacturers in the study specifically represented that their products were "diacetyl free," while the Harvard study seems to indicate that the products did contain diacetyl.
FDA Adds Warnings to SGLT2 Inhibitor Labels
This month the Food and Drug Administration (FDA) has added new warnings to the Type 2 diabetes medications known as SGLT2 Inhibitors. In May of 20-15 FDA issued warnings that the use of these drugs could cause too much acid to be present in the blood, a condition called ketoacidosis. The updated warnings issued in December 2015 reinforce that patients and their doctors should be on the look-out for signs and symptoms of ketoacidosis which include nausea, vomiting, abdominal pain, tiredness and trouble breathing.
Risperdal Verdict Orders Johnson & Johnson to Pay $1.75 Million
A state court jury in Philadelphia has ordered Johnson & Johnson to pay $1.75 million dollars in damages to a young man who developed gynecomastia, or abnormal breast development, while taking the drug. The verdict compensates the young man for disfigurement and mental anguish, among other damages, and signifies a significant step forward for individuals and their families who were harmed by the drug.
By way of background, Johnson & Johnson and its Janssen Pharmaceuticals division are accused of improperly marketing Risperdal for off-label uses and engaging in false and misleading promotional activities, negligently designing the medication, failing to warn consumers of the risks of the medication, and breaching warranties to consumers. In 2013, Johnson & Johnson agreed to pay more than $2.2 billion in criminal and civil fines to the Department of Justice to settle charges that the defendants improperly promoted the antipsychotic drug Risperdal.
Locks Law Firm Attorneys to Serve as Amici for the Supreme Court of New Jersey
Locks Law Firm partner Jonathan Miller and associate James Barry represented the New Jersey Association for Justice (NJAJ) at the Supreme Court of New Jersey as amici. As representatives of the NJAJ, the pre-eminent plaintiff/consumer group in the state of New Jersey, they argued how 2 various cases may affect plaintiffs/consumers across the state.
Mr. Miller, whose almost 40 year history of appellate litigation includes being Chief of Appeals of the Defender Association of Philadelphia, argued two timely issues concerning experts: the sufficiency of the evidence and standards for an expert to render opinions concerning motor vehicle accidents, and whether an adverse inference may be drawn if a defendant does not call its expert to testify.
Planning by Coaches and Trainers is Key to Preventing Heat-Related Injuries on the Playing Field
In the most recent Sports Litigation Alert, Janet Lewis, Director of Sports & Athlete Relations, addresses the need for training and planning to prevent heat related injuries in high school and youth sports. The conclusion: Prevent civil and criminal liability by exercising reasonable care for safety under hot and humid conditions. Instruct athletes on safe procedures and warm them of the risks and dangers so that they, too, can recognize signs of heat injury. By providing medical assistance and creating and following an EAP, the liability for those involved can be greatly reduced, along with the injuries themselves.
YOUTH SPORTS AND THE LAW: Using facemasks on batting helmets
Partner David Langfitt writes for Sporting Kids: Facemasks help prevent concussions and other serious injuries in young baseball and softball players. Are your players protected when they step in the batter’s box?
Senior Partner Marc P. Weingarten named Super Lawyer for 10th year in a row
Senior Partner Marc Weingarten named Super Lawyer for plaintiff product liability for the 10th time in 2015. (Super Lawyers is a rating service of outstanding lawyers from more than 70 practice areas who have attained a high-degree of peer recognition and professional achievement. The selection process includes independent research, peer nominations and peer evaluations. – superlawyers.com). To learn more about Mr. Weingarten’s practice and accomplishments, go to Super Lawyers or view his Locks Law Firm profile.
Concussions in amateur sports: What do we do now?
In his recently published article on mainlinemedianews.com, Attorney David Langfitt discusses the risks associated with concussions and traumatic brain injuries (TBI) in amateur and youth sports. Drawing attention to policies and steps that should be taken when any athlete suffers a hit or blow to the head, he reminds us that, "we should recognize that the excitement the athletes bring us comes with serious risk and cost – and not one of them is getting paid to perform."
Jury Awards $155,000 to Actos Victim
An injured plaintiff was awarded $155,000 in West Virginia for his Actos-related bladder cancer. The jury was only out three hours before it rendered its verdict. This verdict followed right on the heels of a Philadelphia jury verdict of $2 million to another former Actos user. In the recent trial the judge allowed the lawyer for the plaintiff to argue that defendant, Takeda, intentionally destroyed many of its Actos development and marketing files. The US spokesperson for Takeda said that the company is considering its options, which would include an appeal. There are more than 8,000 Actos cases filed around the country, with over 3,500 filed in federal court (which is where Locks Law Firm LLC files its Actos cases).
Actos Verdict for Plaintiff
A jury in Philadelphia found defendant, Takeda, liable for over $2 million for failing to warn that its drug, Actos, can cause bladder cancer, and for causing a 79-year-old woman's bladder cancer. During the three-week-plus trial, Takeda had argued that smoking or other causes were to blame. There have now been seven (7) trials involving claims that Actos caused bladder cancer. The largest verdict, $9 billion earlier this year, is being appealed by Takeda. Two verdicts in favor of plaintiffs (California and Maryland) which combined totalled $8.2 million, were overturned by the trial judge. Three verdicts (two in Las Vegas and one in Illinois) were defense verdicts in favor of Takeda. Evidence shows that Takeda officials destroyed documents about Actos. Actos is a Type-2 diabetes drug which has generated over $16 billion in sales since it was released in 1999. The peak in sales was in the year ending March 2011, at $4.5 billion. Actos accounted for over 25% of Takeda's profits. There are over 3,500 lawsuits consolidated before Judge Rebecca Doherty in federal court in Louisiana. There are another 4,500 cases in state courts in Illinois, Pennsylvania, West Virginia and California.